PMV Pharmaceuticals, Inc.

PMVP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$59-$69-$73-$58
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$12$0$0
Change in WC-$2$5-$1$4
Other Non-Cash$8-$6$9$6
Operating Cash Flow-$51-$56-$64-$47
Investing Activities
PP&E Inv.-$1-$1-$8-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$148-$221-$229-$257
Inv. Sales/Matur.$202$171$236$115
Other Inv. Act.$0$0$0$0
Investing Cash Flow$53-$51-$1-$144
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$35$1$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$36$1$2
Forex Effect-$0$0$0$0
Net Chg. in Cash$2-$71-$64-$188
Supplemental Information
Beg. Cash$39$109$173$361
End Cash$41$39$109$173
Free Cash Flow-$52-$57-$72-$48